Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Olive extract may speed up workout recovery, small study suggests

NCT ID NCT07008586

Knowledge-focused Sponsor: Anglia Ruskin University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether a supplement called OliPhenolia®, made from olives, can reduce inflammation and help healthy adults recover after exercise. 18 people took either the supplement or a placebo before and after a standard workout. Researchers measured blood markers of inflammation and movement quality over several days to see if the supplement made a difference.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

18 people

The number who actually took part.

Started

Jul 2025

Finished

Dec 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

21 to 60 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age ≥ 21 in line with manufacturer recommendations. * Written informed consent. * Willingness and ability to conform to the full protocol (please see full protocol). * Judged by the investigator to be in good health. * To have a pre-study health screen signed off by the lead researcher. Exclusion Criteria: * Current or recent (within the last 4 weeks) engagement with a strict dietary regime i.e., vegetarian / vegan / ketogenic / paleolithic / high protein / weight loss. * Any known issues with blood taking. * Any known bleeding disorders. * Any known allergy to olives, grapes, lemon, coca cola or prunes. * Average alcohol use of \<21 glasses per week for men and \<14 glasses per week for women (on average for the last six months). * Any drug or medicine abuse in the last six months * Known cardiovascular disease, disease related to the immune system (including HIV and hepatitis) and / or the respiratory system. * Known Diabetes Mellitus type I or type II. * Known renal or liver issues or known thyroid dysfunction. * Currently undertaking regular heavy and / or extreme exercise (please discuss with the lead researcher if you are unsure). * Current smoker or stopped smoking for \<one month prior to the first visit. * Current participation in any other clinical study within the month previous to the study start date (discuss with the lead researcher if unsure). * Known pregnancy and / or lactation (women only) * Uncertainty about the willingness or ability of the subject to comply with the protocol requirements.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Healthy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Inflammation Motor Activity

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Healthy

Contacts and locations

Locations

  • Cambridge Centre for Sport and Exercise Sciences, Anglia Ruskin University,

    Cambridge, CB5 8DZ, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.